FPBFX | MPACX | FPBFX / MPACX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 38 years | 21 years | - |
Gain YTD | 11.524 | 10.760 | 107% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 716M | 314M | 228% |
Annual Yield % from dividends | 0.79 | 1.67 | 47% |
Returns for 1 year | 12.39 | 17.29 | 72% |
Returns for 3 years | -27.41 | -37.38 | 73% |
Returns for 5 years | 3.03 | -13.15 | -23% |
Returns for 10 years | 18.74 | 12.47 | 150% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BFTIX | 59.94 | 0.32 | +0.54% |
Baron Fifth Avenue Growth Instl | |||
LVFLX | 14.02 | N/A | N/A |
Lord Abbett Focused Large Cap Value R6 | |||
LBRIX | 32.62 | -0.03 | -0.09% |
ClearBridge Dividend Strategy FI | |||
FAVCX | 24.73 | -0.05 | -0.20% |
Fidelity Advisor Equity Value C | |||
FBTCX | 25.11 | -0.37 | -1.45% |
Fidelity Advisor Biotechnology C |